Digestive system drugs

There are various kinds of digestive diseases with the medication being highly complex and diverse. For the treatment of reflux esophagitis and esophageal diseases, we should apply antacids drugs, especially cimetidine (Tagamet) and so on. H2 receptor blockers have efficacy of neutralizing gastric acid for suppression of gastric acid secretion and reducing the stimulation effect. In recent years, the discovery of metoclopramide (domperidone)’s effect on enhancing the lower esophageal sphincter (LES) tension and its selection application has led to the improved prognosis.

Peptic ulcer and chronic gastritis are common digestive system diseases with high incidence rate and many treatment drugs. However, to date, we are still lack of specific treatment. Antacids drugs for neutralizing gastric acid are still widely used. Conventionally applied sodium bicarbonate, calcium and magnesium have been gradually eliminated. At present time, the commonly used drug is aluminum hydroxide. This drug should be taken in 1 ~ 2h after a meal and can neutralize the stomach acid for up to 3h. Its combination with anticholinergic drugs can alleviate spasm pain as well as inhibit the gastric acid secretion in the evening, doing good to eliminate the peptic ulcer.

At the 1950th to 1960th of the 20th century, commonly used anticholinergic drug is probanthine (propantheline bromide). After the 1970s when the H2 blockers have emerged, the efficacy of treating peptic ulcer has been significantly improved. With the progress of the study, ranitidine, famotidine and other new generations of H2 receptor blocker with stronger antacid effect and reduced side have been applied to clinical practice, leading to excellent results with rapid eliminated symptoms and increased ulcer healing rate.
It is noteworthy that, proton pump inhibitors – omeprazole (Losec) can not only strongly suppress the acid effect, but also increase gastric mucosal blood flow, strengthen the gastric mucosal barrier, playing a more active and effective role in the treatment of this disease.

Currently, the treatment of chronic gastritis, though, is not satisfactory, but for the treatment of bile reflux gastritis, application of aluminum hydroxide and sucralfate to adsorb bile salts and protect gastric mucosal barrier in combination with domperidone can yield good results. In recent years, it has been found that almost all kinds of duodenal ulcers can lead to antral gastritis with Helicobacter pylori (HP) lead to inflammatory lesions in more than 80% cases. Therefore, simultaneously application of some appropriate antibiotic treatment can play a good role in promoting ulcer healing, reducing the relapse, eliminating the inflammation and increasing the efficacy of treatment of peptic ulcer and chronic gastritis. Colloidal bismuth subcitrate can both stimulate mucus secretion, playing a protective role of protecting the gastric mucosal barrier and have certain effect on killing the HP. If being appropriately selected depending on the disease, the rational application of the drugs mentioned above can play a more effective role in improving the efficacy in treating peptic ulcer and chronic gastritis as well as improving the prognosis.

Pepsin and other digestive drugs are now known to have only limited efficacy. For the treatment of chronic pancreatitis caused protein, starch and fat indigestion, pancreatin (pancreatin tablets, multi-enzyme tablets) is still in use, but requiring larger doses to be effective.

There are not many domestic pharmaceutical formulations for treating constipation with commonly used laxatives including milk of Magnesia, phenolphthalein and liquid paraffin. There is very limited domestic application of antidiarrheal opiates agents. Commonly used include aluminum hydroxide gel and diphenoxylate. It is worth noting that the latter one has a similar effect as pethidine and is often prone to be addicted and thus being not appropriate for long-term use. Lactulose is a special indigestible type of disaccharide, being able to be decomposed into lactose and acetate in large intestine, playing the osmotic laxative effect. Acidified manure can inhibit the intestinal bacteria from producing ammonia, and enable ammonia to diffuse into the lumen of the colon. Therefore, it has effect of lowering blood ammonia, having certain therapeutic effect on the treatment of hepatic coma.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Alibendol Alibendol 26750-81-2 C13H17NO4
Sofalcone Sofalcone 64506-49-6 C27H30O6
Alvimopan Alvimopan 156053-89-3 C25H32N2O4
REBAMIPIDE REBAMIPIDE 111911-87-6 C19H15ClN2O4
Esomeprazole Esomeprazole 119141-88-7 C17H19N3O3S
Lorcaserin hydrochloride Lorcaserin hydrochloride 846589-98-8 C11H15Cl2N
Dolasetron mesylate Dolasetron mesylate 115956-13-3 C20H26N2O7S
Omeprazole Omeprazole 73590-58-6 C17H19N3O3S
Aprepitant Aprepitant 170729-80-3 C23H21F7N4O3
Dioctyl sulfosuccinate sodium salt Dioctyl sulfosuccinate sodium salt 577-11-7 C20H37O7S.Na
3-Methoxy-1-propanol 3-Methoxy-1-propanol 1589-49-7 C4H10O2
Lansoprazole Lansoprazole 103577-45-3 C16H14F3N3O2S
Esomeprazole sodium Esomeprazole sodium 161796-78-7 C34H36MgN6O6S2
Oleanolic acid Oleanolic acid 508-02-1 C30H48O3
Cholic acid Cholic acid 81-25-4 C24H40O5
Racecadotril Racecadotril 81110-73-8 C21H23NO4S
R-(-)-Apomorphine R-(-)-Apomorphine 41372-20-7 C17H20ClNO3
Rabeprazole Rabeprazole 117976-89-3 C18H21N3O3S
GLYCOCHOLIC ACID SODIUM SALT GLYCOCHOLIC ACID SODIUM SALT 863-57-0 C26H42NNaO6
Glycyrrhizic acid Glycyrrhizic acid 1405-86-3 C42H62O16
Dehydrocholic acid Dehydrocholic acid 81-23-2 C24H34O5
Ursodeoxycholic acid Ursodeoxycholic acid 128-13-2 C24H40O4
5-Aminosalicylic acid 5-Aminosalicylic acid 89-57-6 C7H7NO3
Glycyrrhizic acid ammonium salt Glycyrrhizic acid ammonium salt 53956-04-0 C42H65NO16
Tiopronin Tiopronin 1953-02-2 C5H9NO3S
Calcium carbonate Calcium carbonate 471-34-1 CCaO3
LITHOCHOLIC ACID LITHOCHOLIC ACID 434-13-9 C24H40O3
K-CATALYST K-CATALYST 1318-93-0 Al2O9Si3
Rabeprazole Sodium Rabeprazole Sodium 117976-90-6 C18H21N3O3S.Na
Orlistat Orlistat 96829-58-2 C29H53NO5
Rasagiline Rasagiline 136236-51-6 C12H13N
Lipoic acid Lipoic acid 62-46-4 C8H14O2S2
Citric acid monohydrate Citric acid monohydrate 5949-29-1 C6H10O8
Sodium sulfate Sodium sulfate 7757-82-6 Na2SO4
Phenolphthalein Phenolphthalein 77-09-8 C20H14O4
1,8-Dihydroxyanthraquinone 1,8-Dihydroxyanthraquinone 117-10-2 C14H8O4
Cimetidine Cimetidine 51481-61-9 C10H16N6S
Chenodeoxycholic acid Chenodeoxycholic acid 474-25-9 C24H40O4
L-carnitine L-carnitine 541-15-1 C7H15NO3
L-Carnitine-L-tartrate L-Carnitine-L-tartrate 36687-82-8 C11H20NO9-
Ilaprazole Ilaprazole 172152-36-2 C19H18N4O2S
Castor oil Castor oil 8001-79-4 C57H104O9
Aloin Aloin 1415-73-2 C21H22O9
Glycerol Glycerol 56-81-5 C3H8O3
Famotidine Famotidine 76824-35-6 C8H15N7O2S3
Bismuth(III) Oxide Bismuth(III) Oxide 1304-76-3 Bi2O3
4-Methylumbelliferone 4-Methylumbelliferone 90-33-5 C10H8O3
Diisopropylamine Diisopropylamine 108-18-9 C6H15N
Esomeprazole magnesium Esomeprazole magnesium 161973-10-0 C34H36MgN6O6S2
ALOSETRON ALOSETRON 122852-42-0 C17H18N4O
Loperamide hydrochloride Loperamide hydrochloride 34552-83-5 C29H34Cl2N2O2
Magnesium oxide Magnesium oxide 1309-48-4 MgO
3-Phenyl-1-propanol 3-Phenyl-1-propanol 122-97-4 C9H12O
Granisetron Hydrochloride Granisetron Hydrochloride 107007-99-8 C18H24N4O.ClH
R-(+)-Lansoprazole R-(+)-Lansoprazole 138530-94-6 C16H14F3N3O2S
Ulgut Ulgut 91574-91-3 C65H98ClN3O39
SP 303 SP 303 148465-45-6 C18H16N2O3
Efinopegdutide Efinopegdutide 2055640-93-0
fencibutirol fencibutirol 5977-10-6 C16H22O3
ALUMINIUMCARBONATE ALUMINIUMCARBONATE 53547-27-6
Odevixibat Odevixibat 501692-44-0 C37H48N4O8S2
Seladelpar lysine Seladelpar lysine 928821-40-3 C27H37F3N2O7S
Glycopyrronium tosylate Glycopyrronium tosylate 1624259-25-1 C26H35NO6S
Giminabant Giminabant 890033-57-5 C26H22Cl2N4
Lurosetron mesylate Lurosetron mesylate 143486-90-2 C18H21FN4O4S
Ibipinabant Ibipinabant 464213-10-3 C23H20Cl2N4O2S
PARGEVERINE HCL PARGEVERINE HCL 13479-13-5 C21H23NO3
DEVAZEPIDE DEVAZEPIDE 103420-77-5 C25H20N4O2
Condurango, ext. Condurango, ext. 84787-66-6
butropium bromide butropium bromide 29025-14-7 C28H38NO4.Br
pentapiperium metilsulfate pentapiperium metilsulfate 7681-80-3 C19H30NO2.CH3O4S
betaine aspartate betaine aspartate 52921-08-1 C9H18N2O6
(±)-3-[(1-methyl-2-phenylethyl)amino]propiononitrile hydrochloride (±)-3-[(1-methyl-2-phenylethyl)amino]propiononitrile hydrochloride 18305-29-8 C12H17ClN2
Benzoic acid, 4-[4-[[1,4-dihydro-1-(1-methylethyl)-7-oxospiro[5H-indazole-5,4′-piperidine]-1′(6H)-yl]carbonyl]-6-methoxy-2-pyridinyl]-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) Benzoic acid, 4-[4-[[1,4-dihydro-1-(1-methylethyl)-7-oxospiro[5H-indazole-5,4′-piperidine]-1′(6H)-yl]carbonyl]-6-methoxy-2-pyridinyl]-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) 2334472-62-5 C28H30N4O5.C4H11NO3
N-(1,3-benzodioxol-5-ylmethyl)-N'-[2-[[5-[(dimethylamino)methyl]furfuryl]thio]ethyl]-2-nitrovinylidenediamine N-(1,3-benzodioxol-5-ylmethyl)-N'-[2-[[5-[(dimethylamino)methyl]furfuryl]thio]ethyl]-2-nitrovinylidenediamine 84845-75-0 C20H26N4O5S
2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with α,α-diphenyl-1-piperidinebutanol (1:2) (9CI) 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with α,α-diphenyl-1-piperidinebutanol (1:2) (9CI) 26363-46-2 C44H43NO7
Ulinastatin Ulinastatin 80449-31-6 C13H16O3
Lactobacilluscasei Lactobacilluscasei 68333-14-2
CYCLIZINE LACTATE CYCLIZINE LACTATE 5897-19-8 C21H28N2O3
Picoprazole Picoprazole 78090-11-6 C17H17N3O3S
Polyethadene Polyethadene 9003-23-0 C4H4O2X2.C2H3NX2
Benzoic acid, 2-(acetyloxy)-, mixt. with 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Benzoic acid, 2-(acetyloxy)-, mixt. with 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole 1259513-22-8 C26H27N3O7S
intacellin intacellin 82391-92-2
Pegozafermin Pegozafermin 2489589-60-6
Difemerine Difemerine 80387-96-8 C20H25NO3
Fk 1052 Fk 1052 129299-90-7 C18H20ClN3O
Relenopride Relenopride 1221416-42-7 C24H31Cl2FN4O4
Morphinan-7-carboxamide, 17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]-, (5α)-, 4-methylbenzenesulfonate (1:1) Morphinan-7-carboxamide, 17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]-, (5α)-, 4-methylbenzenesulfonate (1:1) 1345728-04-2 C32H34N4O6.C7H8O3S
FGXWKSZFVQUSTL-GYABSUSNSA-N FGXWKSZFVQUSTL-GYABSUSNSA-N 2121525-08-2 C22H24ClN5O2
Naronapride dihydrochloride Naronapride dihydrochloride 860169-57-9 C27H41ClN4O5. 2HCl
PHENMETRAZINE HYDROCHLORIDE CII (200 MG) PHENMETRAZINE HYDROCHLORIDE CII (200 MG) 1707-14-8 C11H15NO.ClH
THIETHYLPERAZINE MALATE (200 MG) THIETHYLPERAZINE MALATE (200 MG) 52239-63-1 C30H41N3O10S2
Methylbenactyzine bromide Methylbenactyzine bromide 3166-62-9 C21H30BrNO4
flumeridone flumeridone 75444-64-3 C22H23ClFN5O2
dicycloverine dicycloverine 77-19-0 C19H35NO2
etomidoline etomidoline 21590-92-1 C23H29N3O2
benzilonium bromide benzilonium bromide 1050-48-2 C22H28BrNO3
[7(S)-(1alpha2beta,4beta,5alpha,7beta)]-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane methyl sulphate [7(S)-(1alpha2beta,4beta,5alpha,7beta)]-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane methyl sulphate 18067-13-5 C19H27NO8S
oxyphencyclimine oxyphencyclimine 125-53-1 C20H28N2O3
choline stearate choline stearate 23464-76-8 C23H49NO3
HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase
Copyright © 2016 ChemicalBook All rights reserved.